首页> 外国专利> PHARMACEUTICAL COMPOSITION COMPRISING LINAGLIPTIN, METFORMIN AND ANTIOXIDANT WITH IMPROVED STABILITY

PHARMACEUTICAL COMPOSITION COMPRISING LINAGLIPTIN, METFORMIN AND ANTIOXIDANT WITH IMPROVED STABILITY

机译：包含林格列汀，二甲双胍和抗氧化剂的药物组合物，具有增强的稳定性

页面导航

摘要
著录项
相似文献

摘要

The present invention relates to a pharmaceutical composition comprising a linagliptin, metformin and antioxidant with improved stability. The pharmaceutical composition can further contain an alkaline stabilizer. According to the present invention, the pharmaceutical composition inhibits production of related substances of linagliptin which are used as an active component, thereby preserving stability regardless of long period of storage.;COPYRIGHT KIPO 2019

机译：本发明涉及药物组合物，其包含具有改善的稳定性的利拉列汀，二甲双胍和抗氧化剂。该药物组合物可以进一步包含碱性稳定剂。根据本发明，所述药物组合物抑制了用作活性成分的利格列汀的相关物质的产生，从而不管长期保存都保持稳定性。; COPYRIGHT KIPO 2019

著录项

公开/公告号KR20190003914A

专利类型
公开/公告日2019-01-10

原文格式PDF
申请/专利权人 HANMI PHARM. CO. LTD.;
展开▼

申请/专利号KR20170083831
发明设计人 YOON YOUNG MINKR;KWON TAEK KWANKR;IM HO TAEKKR;KIM YONG ILKR;
展开▼

申请日2017-06-30
分类号A61K9/20;A61K31/155;A61K31/522;A61K9;
国家 KR
入库时间 2022-08-21 11:51:53

相似文献

专利
外文文献
中文文献